Table 4: Studies related to FN bacteraemia in pediatric patients with hematology-oncology disorders. |
||||
Article |
Incidence |
Bacteriemias, n |
Microorganisms |
n (%) |
Greenberg14 Israel (2005) |
37.27% (41/110) patients |
132 |
Gram-negative bacteria |
86 (65.00) |
Klebsiella spp. |
20 (15.20) |
|||
CNS |
15 (11.40) |
|||
Pseudomonas spp. |
14 (10.60) |
|||
Streptococcus spp. |
13 (9.80) |
|||
Enterobacter spp. |
12 (9.10) |
|||
E. coli |
11 (8.30) |
|||
El-mahallawy15 Egypt (2011) |
|
239 |
Gram-positive bacteria |
180 (75.00) |
CNS |
116 (48.50) |
|||
Streptococcus spp. |
29 (12.10) |
|||
S. aureus |
23 (9.60) |
|||
Cortez16 Chile (2012) |
|
95 |
Gram-positive bacteria |
56 (59.00) |
CNS |
29 (30.20) |
|||
S. group viridans |
13 (5.00) |
|||
S. aureus |
10 (4.00) |
|||
SolĂs17 Chile (2012) |
21.57% (181/839) episodes |
181 |
Gram-positive bacteria |
101 (56.04) |
CNS |
45 (25.00) |
|||
E. coli |
36 (20.00) |
|||
S. group viridans |
25 (14.00) |
|||
S. aureus |
24 (13.00) |
|||
Pseudomonas spp. |
16 (9.00) |
|||
Miedema18 Germany (2013) |
|
248 |
Gram-positive bacteria |
180 (73.00) |
CNS |
96 (39.00) |
|||
Streptococcus spp. |
65 (26.00) |
|||
Reddy19 India (2014) |
4.13% (27/653) episodes |
27 |
Gram-negative bacteria |
25 (92.00) |
Klebsiella spp. |
13 (48.00) |
|||
Acinetobacter spp. |
6 (22.00) |
|||
Al-Mulla20 Qatar (2014) |
37.83% (70/185) patients |
111 |
Gram-positive bacteria |
64 (57.00) |
CNS |
42 (38.00) |
|||
Klebsiella spp. |
14 (13.00) |
|||
Pseudomonas spp. |
10 (9.00) |
|||
E. coli |
7 (6.00) |
|||
El-Mahallawy21 Egypt (2015) |
|
232 |
Gram-positive bacteria |
168 (72.00) |
CNS |
135 (58.20) |
|||
Streptococcus spp. |
16 (6.90) |
|||
S. aureus |
13 (5.60) |
|||
Tural Kara22 Turkey (2019) |
|
111 |
Gram-negative bacteria |
(60.50%) |
E. coli |
19 (16.70) |
|||
CNS |
19 (16.70) |
|||
Klebsiella spp. |
15 (13.20) |
|||
Pseudomonas spp. |
12 (10.50) |
|||
Enterococcus spp. |
9 (7.90) |
|||
FN = febrile neutropenia; CNS = coagulase-negative staphylococci. |